Evidence map›Paper›PMID 36267923›Full record

ArticleTanaffos2021

Frequency of Multi-Drug Resistance and Molecular Characteristics of Resistance to Colistin in

Samaneh Babaei, Mihan Pourabdollah, Masoumeh Aslanimehr, Farhad Nikkhahi, Saeid Mahmoodian, Yasaman Hasani, Fatemeh Maryam Sheikholeslami

Open access · greenAbstract read
PubMed Full text at PMC
In one paragraph

Article in Tanaffos, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.1field-weighted citation impact, top 60% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Phage Cocktail againstInternational journal of molecular and cellular medicine · 2025
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Samaneh BabaeiNational Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Science, Tehran, Iran.
Mihan PourabdollahChronic Respiratory Disease Research Center, NRITLD, Shahid Beheshti University of Medical Science, Tehran, Iran.
Masoumeh AslanimehrMedical Microbiology Research Center, Qazvin University of Medical Sciences, Qazvin, Iran.
Farhad NikkhahiMedical Microbiology Research Center and Cellular and Molecular Research, Qazvin University of Medical Sciences, Qazvin, Iran.
Saeid MahmoodianChronic Respiratory Disease Research Center, NRITLD, Shahid Beheshti University of Medical Science, Tehran, Iran.
Yasaman HasaniLaboratory of Sciences, Shahid Beheshti University of Medical Science, Tehran, Iran.
Fatemeh Maryam SheikholeslamiPediatric Respiratory Diseases Research Center, Shahid Beheshti University of Medical Science, Tehran, Iran.
Masih Daneshvari Hospital · IRQazvin University of Medical Sciences · IRShahid Beheshti University · IRShahid Beheshti University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Materials and Methods: In this study, 200 A Results: All the isolates were susceptible to colistin. Moreover, they were resistant to piperacillin, piperacillin-tazobactam, ceftazidime, cefotaxime, ceftriaxone, amikacin, gentamycin, levofloxacin, co-trimoxazole, and ciprofloxacin. Antimicrobial resistance rates for tetracycline and ampicillinsulbactam were 8.5% and 20%, respectively. All isolates were MDR and XDR. All isolates were susceptible to colistin (MIC50=1 and MIC90=2 μg/ml). The sequencing results did not show any point mutation in Conclusion: In this study, all

Indexed as

Acinetobacter baumanniiColistinmcr-1MDRpmr CABXDR

Identifiers

PMID36267923
PMCPMC9577206
OpenAlexW4307036023

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.